Scott Pattison

Targeted Doxorubicin Delivery to Brain Tumors via Minicells: Proof of Principle Using Dogs with Spontaneously Occurring Tumors as a Model

G. Gallia, D. Bailey, B. Stillman, 2016, PloS one.

Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study.

D. Bailey, N. Pavlakis, M. Fulham, 2017, The Lancet. Oncology.

Targeted nanoparticle delivery of doxorubicin into placental tissues to treat ectopic pregnancies.

T. Johns, A. Horne, J. Macdiarmid, 2013, Endocrinology.

A First-Time-In-Human Phase I Clinical Trial of Bispecific Antibody-Targeted, Paclitaxel-Packaged Bacterial Minicells

J. Desai, A. Scott, B. Solomon, 2015, PloS one.

Sequential treatment of drug-resistant tumors with targeted minicells containing siRNA or a cytotoxic drug

B. Stillman, S. Wetzel, J. Macdiarmid, 2009, Nature Biotechnology.

P1.02MesomiR 1: A Phase I study of TargomiRs in patients with refractory malignant pleural mesothelioma (MPM) and lung cancer (NSCLC)

N. Pavlakis, G. Reid, S. Clarke, 2015 .